Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 130 participants.
Also called NCT01151176
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 130 participants
- Sponsor
- Registry
-
NCT01151176
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Brazil
- Registry status
- Suspended
Technical summary
Registry record NCT01151176. Randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2013-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Regular Insulin
- Intervention (Drug)
- Regular Insulin
- Lead sponsor
- Universidade Positivo
- Collaborator
- Emory University
Record details
- Record id
cardio:ct-nct01151176- Content hash
d1932fe83ac02b81d45f224d325ae2580b7af56547a68b51440d7cabf2d47804